Search the Newsreel

Novanta Inc (NOVT) Financial Health: Profitability & Balance Sheet Analysis

Novanta Inc (NOVT) has a robust financial status with a current score of 7.33, ranking 27th in its industry. The company reported a latest quarterly revenue of $257.71 million, showing a 10.43% year-over-year increase, and a net profit increase of 0.51% year-over-year. While its …

NOVT|Novanta Inc|Price:137.890|Chg%:-3.730

Novanta Inc. (NOVT) is a supplier of core technology solutions for medical and advanced industrial original equipment manufacturers, with segments in Automation Enabling Technologies and Medical Solutions. The company's stock is currently priced at $137.770, with a market cap of $4.91 billion and a …

Novanta Inc (NOVT) Institutional Confidence

Novanta Inc (NOVT) has an institutional shareholding score of 10.00, placing it first in the Electronic Equipment & Parts industry. The institutional shareholding proportion has increased by 22.19% quarter-over-quarter, now standing at 129.80%. Ron Baron is the largest institutional shareholder, holding 2.56% of shares …

Novanta (NOVT) Projected to Release Quarterly Earnings on Wednesday

Novanta (NOVT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Will Novanta (NOVT) Beat Estimates Again in Its Next Earnings Report?

NOVT|Novanta Inc|Price:140.775|Chg%:-0.765

This article provides a comprehensive stock analysis of Novanta Inc (NOVT) from TradingKey, highlighting its strong fundamentals and significant growth potential. The company's valuation is considered fair, ranking 16th in its industry, with high institutional ownership and multiple "Strong Buy" ratings from analysts. Despite …

Novanta Expects Riverpoint Deal to Double Medical Consumables Revenue

Novanta Inc Revenue Breakdown – TRADEGATE:1GSN

Novanta Inc (1GSN) generated €834.90 million in revenue last year. Its top-performing segment, Automation Enabling Technologies, contributed €426.42 million, while the United States was the largest regional contributor with €441.89 million in revenue. The article provides a high-level overview of the company's financial performance …

Novanta Inc (NOVT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Novanta Inc (NOVT), focusing on its support and resistance levels, various technical indicators, and moving averages. Currently, Novanta Inc's stock is trading between a resistance of $159.05 and a support of $131.73, indicating suitability for range-bound swing …

Behavioral Patterns of NOVT and Institutional Flows

This article analyzes behavioral patterns and institutional flows for Novanta Inc. (NASDAQ: NOVT), highlighting weak near and mid-term sentiment that could challenge a positive long-term outlook. It presents AI-generated trading strategies for different risk profiles, including long, breakout, and short positions, along with multi-timeframe …

Novanta (NOVT) Is Down 5.1% After Softer Sales And Earnings Momentum Raises Durability Questions

Novanta (NOVT) shares dropped 5.1% after concerns emerged regarding its softer sales and earnings momentum, raising questions about the durability of its business performance. The company's recent sales growth has been below average, and its earnings growth has lagged peers, despite reaffirming its 2026 …

Press Release: Novanta Inc. Announces Schedule of Second Quarter 2026 Earnings Release and Conference Call

Novanta Inc. has announced it will release its second quarter 2026 financial results on Tuesday, August 2, 2026, after the market closes. The company will also host a conference call and live webcast at 5:00 p.m. ET on the same day to discuss these …

NOVANTA INC TANGIBLE EQUITY UNIT(01/11/2028) To Go Ex-Dividend On July 31st, 2026 With 0.8125 USD Dividend Per Share

NOVANTA INC TANGIBLE EQUITY UNIT (01/11/2028) is scheduled to go ex-dividend on July 31st, 2026. The company will issue a dividend of 0.8125 USD per share. Investors should note this date for dividend eligibility.

Novanta Acquires Riverpoint Medical for Up to $1.45 Billion

Novanta Inc. (NASDAQ: NOVT) has signed a definitive agreement to acquire Riverpoint Medical from Arlington Capital Partners for an initial payment, with the potential for the total acquisition cost to reach up to $1.45 billion. Ropes & Gray advised Novanta on this transaction. The …